New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
14:51 EDTMDXGMiMedx addressed reimbursement fears on call, says Craig-Hallum
Craig-Hallum said MiMedx management outlined reimbursement scenarios for when the company no longer has pass-through status, calming the fears of some investors. Craig-Hallum also noted that the company raised the lower-end of its FY14 revenue guidance to $95M from $90M and that management said its meeting with the FDA about its micronized injectable products was both "productive and helpful." The firm reiterates its Buy rating and $10 price target on MiMedx.
News For MDXG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
09:17 EDTMDXGMiMedx Q4 results likely to beat consensus, says Needham
Subscribe for More Information
December 15, 2014
08:50 EDTMDXGMiMedx sees Q1 revenue $40M-$41M, consensus $39.26M
Sees Q1 operating profit margin to be in excess of 10%. Sees FY15 operating profit margin to be in excess of 15%.
08:48 EDTMDXGMiMedx raises FY15 revenue view to $190M from $175M, consensus $181.1M
Subscribe for More Information
December 11, 2014
09:35 EDTMDXGMiMedx management to meet with Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use